Lyanne Harrison

Stock Analyst at Bank of America Securities

(1.08)

# 3,871

Out of 5,082 analysts

55

Total ratings

53.8%

Success rate

-2.5%

Average return

Main Sectors:

Top Industries:

Medical Instruments & Supplies Diagnostics & Research Medical Devices Medical Distribution

Stocks Rated by Lyanne Harrison

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	RMD ResMed	Reiterated: Buy	$320	$250.80	+27.59%	43	Oct 13, 2026
	ASX: ACL Australian Clinical Labs Limited	Upgraded: Buy	$3.60	$2.95	n/a	1	Jun 23, 2025
	RCEL AVITA Medical	Reiterated: Buy	n/a	$16.08	n/a	10	Aug 9, 2024
	ASX: SIG Sigma Healthcare Limited	Upgraded: Hold	$0.85	$2.76	n/a	1	Jun 7, 2023

ResMed

Oct 13, 2026

Reiterated: Buy

Price Target: $320

Current: $250.80

Upside: +27.59%

Australian Clinical Labs Limited

Jun 23, 2025

Upgraded: Buy

Price Target: $3.60

Current: $2.95

Upside: n/a

AVITA Medical

Aug 9, 2024

Reiterated: Buy

Price Target: n/a

Current: $16.08

Upside: n/a

Sigma Healthcare Limited

Jun 7, 2023

Upgraded: Hold

Price Target: $0.85

Current: $2.76

Upside: n/a